Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
4
×
boston blog main
boston top stories
life sciences
national blog main
startups
4
×
national top stories
new york blog main
clinical trials
new york top stories
third rock ventures
venture capital
20/20 healthcare partners
adeno-associated virus
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
antisense oligonucleotide
azacitidine
benzodiazepines
beta-thalassemia
biogen
blackstone group
blackstone life sciences
cancer
chemotherapy
christian angermayer
cisplatin
columbia university
dacogen
david goldstein
deals
decibel therapeutics
decitabine
depression
dna
dolby family ventures
enclear therapies
epi4k
What
drugs
4
×
medicines
new
aims
neuro
research
therapeutics
adding
ago
aiming
approach
associated
backed
balance
based
biotech
build
called
cause
ceo
companies
debuts
decibel
develop
developing
device
dialysis
disease
diseases
emerged
enclear
epigenetic
epigenetics
epilepsy
field
flagship’s
focus
forms
genes
genetic
Language
unset
Current search:
drugs
×
startups
×
boston
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further